MX2021005246A - Actividad antidiabetica del extracto de neem y combinaciones sinergicas de urolitinas a y b. - Google Patents

Actividad antidiabetica del extracto de neem y combinaciones sinergicas de urolitinas a y b.

Info

Publication number
MX2021005246A
MX2021005246A MX2021005246A MX2021005246A MX2021005246A MX 2021005246 A MX2021005246 A MX 2021005246A MX 2021005246 A MX2021005246 A MX 2021005246A MX 2021005246 A MX2021005246 A MX 2021005246A MX 2021005246 A MX2021005246 A MX 2021005246A
Authority
MX
Mexico
Prior art keywords
urolithins
neem extract
synergistic combinations
diabetic activity
neem
Prior art date
Application number
MX2021005246A
Other languages
English (en)
Spanish (es)
Inventor
Muruganandam A Veeraragavan
Chandan K Sen
Sanyasi R Kalidindi
Original Assignee
Natreon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natreon Inc filed Critical Natreon Inc
Publication of MX2021005246A publication Critical patent/MX2021005246A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2021005246A 2018-11-05 2019-11-05 Actividad antidiabetica del extracto de neem y combinaciones sinergicas de urolitinas a y b. MX2021005246A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201841041788 2018-11-05
US16/672,743 US20200138892A1 (en) 2018-11-05 2019-11-04 Anti-diabetic activity of neem extract and synergistic combinations of urolithins a and b
PCT/US2019/059774 WO2020097014A1 (en) 2018-11-05 2019-11-05 Anti-diabetic activity of neem extract and synergistic combinations of urolithins a and b

Publications (1)

Publication Number Publication Date
MX2021005246A true MX2021005246A (es) 2021-09-08

Family

ID=70460249

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021005246A MX2021005246A (es) 2018-11-05 2019-11-05 Actividad antidiabetica del extracto de neem y combinaciones sinergicas de urolitinas a y b.

Country Status (10)

Country Link
US (1) US20200138892A1 (cg-RX-API-DMAC7.html)
EP (1) EP3876968A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022536223A (cg-RX-API-DMAC7.html)
KR (1) KR20210096121A (cg-RX-API-DMAC7.html)
CN (1) CN113226347A (cg-RX-API-DMAC7.html)
AU (1) AU2019377432A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021008725A2 (cg-RX-API-DMAC7.html)
CA (1) CA3118926A1 (cg-RX-API-DMAC7.html)
MX (1) MX2021005246A (cg-RX-API-DMAC7.html)
WO (1) WO2020097014A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220098228A1 (en) * 2020-09-28 2022-03-31 Natreon, Inc. Methods and compositions for improving the immune system and providing immuno-protection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8206753B2 (en) * 2001-06-20 2012-06-26 Metaproteomics, Llc Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
JP2005325025A (ja) * 2004-05-12 2005-11-24 Green Kanpo Seiyaku Kk 糖尿病予防・治療組成物
EP1807098A1 (en) * 2004-09-13 2007-07-18 Amcod Limited Herbal compositions for treatment of diabetes

Also Published As

Publication number Publication date
JP2022536223A (ja) 2022-08-15
KR20210096121A (ko) 2021-08-04
AU2019377432A1 (en) 2021-06-10
EP3876968A1 (en) 2021-09-15
US20200138892A1 (en) 2020-05-07
WO2020097014A1 (en) 2020-05-14
CN113226347A (zh) 2021-08-06
CA3118926A1 (en) 2020-05-14
EP3876968A4 (en) 2022-09-14
BR112021008725A2 (pt) 2021-08-03

Similar Documents

Publication Publication Date Title
WO2019006005A3 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF MELANOMA
PH12018501969A1 (en) Pharmaceutical composition comprising empagliflozin and uses thereof
MX2023012450A (es) Esketamina para el tratamiento de la depresion.
PH12020551427A1 (en) Epinephrine spray formulations
SG11201811697SA (en) Glucagon derivative, conjugate thereof, composition comprising same and therapeutic use thereof
MX2021013354A (es) Metodos para tratar y/o prevenir queratosis actinica.
MX2023005014A (es) Metodos de tratamiento de enfermedades inflamatorias cronicas.
MX2020011817A (es) Metodos para tratar el linfoma.
PH12020552241A1 (en) Use of polar lipids to treat or prevent gestational diabetes mellitus
WO2018025080A3 (en) Compositions for enhancing brain activity
SG10201906172XA (en) Regulation of glucose metabolism using anti-cgrp antibodies
MX2020010302A (es) Uso de ácido (1s,3s)-3-amino-4-(difluorometilideno)ciclopentano-1- carboxílico y ácido (s)-3-amino-4-(difluorometilenil)ciclopent-1-e no-1-carboxílico en eltratamiento contra trastornos oculares.
MX2018005352A (es) Metodos y composiciones para el tratamiento de amiloidosis.
MX2021006933A (es) Administración de sulcardina para el tratamiento de fibrilación auricular aguda.
MY203497A (en) Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments
NZ754706A (en) Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
EP4438057A3 (en) Compositions and methods of treating lupus nephritis
MX2019003725A (es) Glicinato de metformina, composiciones farmaceuticas que comprenden la misma, y metodos de uso de la misma.
PH12020500489A1 (en) Methods and compositions for treating chronic lung diseases
MX2018014129A (es) Composiciones farmaceuticas de oligomero de morfolino fosforodiamidato.
ZA202200273B (en) Animal food composition
PH12018500817A1 (en) Pharmaceutical composition comprising metformin and lobeglitazone
EP4470625A3 (en) A pharmaceutical composition comprising a combination of probiotic and prebiotic to treat stunting
Hamidpour et al. Sage: The functional novel natural medicine for preventing and curing chronic illnesses
MX2018002298A (es) Metodos de uso de interleucina 10 para el tratamiento de enfermedades y trastornos.